{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: However , a 38 % remission rate has been recently reported in refractory MCL treated with temsirolimus , a mTOR inhibitor . Here we had the opportunity to study a case of refractory MCL who had tumor regression two months after temsirolimus treatment , and a progression - free survival of 10 months .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| MCL (Mantle Cell Lymphoma) |\n| refractory MCL (refractory Mantle Cell Lymphoma) |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| Mantle Cell Lymphoma (MCL) |\n| refractory Mantle Cell Lymphoma (refractory MCL) |"}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: However , a 38 % remission rate has been recently reported in refractory MCL treated with temsirolimus , a mTOR inhibitor . Here we had the opportunity to study a case of refractory MCL who had tumor regression two months after temsirolimus treatment , and a progression - free survival of 10 months .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| temsirolimus |\n| mTOR |\n\nIn the given paragraph, the only two chemical entities mentioned are \"temsirolimus\" and \"mTOR\". \"mTOR\" stands for mammalian target of rapamycin, which is a protein, but in this context, it is often referred to as the mTOR complex or mTOR inhibitors, so it is listed as a chemical entity."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| temsirolimus |\n\nIn the given paragraph, only \"temsirolimus\" is a clear chemical entity. \"mTOR\" is a protein and is often referred to as a target or a complex, but in this context, it is mentioned in relation to temsirolimus as an mTOR inhibitor, so it is listed as a chemical entity."}
  ]
}